Physician
Neurology
Dr. William A. Sheremata, MD
|
|
Give Review
William Sheremata works in the field of Neurology. Doctor William A. Sheremata, MD is a published doctor and has 89 publications published. The lastest was: 'HTLV-II risk factors in Native Americans in Florida.' William A. Sheremata accepts all Medicare patients.
Publications
- Increased seroreactivity to HRES-1 Gag peptides in patients with HTLV myelopathy.
- Multiple sclerosis and the spinal cord.
- Association between paroxysmal tonic spasms and neuromyelitis optica.
- Impact of rituximab on relapse rate and disability in neuromyelitis optica.
- Parkinsonism/dystonia syndrome secondary to multiple sclerosis with anti-basal-ganglia antibodies.
- Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis.
- Epidemiologic features of HTLV-II: serologic and molecular evidence.
- LGL leukemia and HTLV.
- Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports.
- Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis.
- The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications.
- The role of CD4+ T-cells in the development of MS.
- Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis.
- Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
- Evidence of platelet activation in multiple sclerosis.
- Transient movement disorders and multiple sclerosis.
- A controlled trial of natalizumab for relapsing multiple sclerosis.
- Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum.
- Spastic ataxia associated with human T-cell lymphotropic virus type II infection.
- Natural alpha interferon in multiple sclerosis: results of three preliminary series.
- Cell-mediated hypersensitivity and disease activity in multiple sclerosis.
- Peripheral nerve myelin P2 protein in influenza vaccine.
- The hot bath test and multiple sclerosis.
- Neurogenic bladder dysfunction in the Shy-Drager syndrome.
- Experimental embolic stroke in the guinea pig (Cuvis cobaya).
- Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy.
- Clinical spectrum of HTLV-I in south Florida.
- Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
- Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report.
- Studies of cellular sensitization to myelin antigens in multiple sclerosis. Dissociation of MIF and LBT production in response to a peptide encephalitogenic in rhesus ...
- Cellular and humoral responses to myelin basic protein in multiple sclerosis: a dichotomy.
- Responses of purified T-cells to mitogens and myelin basic protein in multiple sclerosis.
- Cellular hypersensitivity to basic myelin (P2) protein in the Guillain-Barré syndrome.
- Sensitization to myelin basic protein in attacks of multiple sclerosis. A preliminary report.
- Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.
- Cellular hypersensitivity in attacks of multiple sclerosis. I. A comparative study of migration inhibitory factor production and lymphoblastic transformation in respon...
- Retrobulbar neuritis. In vitro evidence of sensitization to myelin basic protein in patients without multiple sclerosis.
- The role of viruses in the pathogenesis of demyelinative disorder.
- Multiple sclerosis and cell-mediated hypersensitivity to myelin A1 protein.
- Direct leukocyte migration inhibition by myelin basic protein in exacerbations of multiple sclerosis.
- Antimyelin basic protein antibodies and cellular hypersensitivity in multiple sclerosis.
- Cerebrospinal fluid T and B lymphocyte kinetics related to exacerbations of multiple sclerosis.
- Cerebrospinal fluid T & B lymphocyte responses in exacerbations of multiple sclerosis.
- Cellular hypersensitization to peripheral nervous antigens in the Guillain-Barré syndrome.
- Relapsing and remitting human immunodeficiency virus-associated leukoencephalomyelopathy.
- Multiple sclerosis sibling pairs: clustered onset and familial predisposition.
- HTLV-I infection of cerebrospinal fluid T cells from patients with chronic neurologic disease.
- Atypical Creutzfeldt-Jakob disease in an American family with an insert mutation in the PRNP amyloid precursor gene.
- Immunologic mechanisms in experimental encephalomyelitis in nonhuman primates.
- Hypersensitivity to myelin protein preceding attacks of multiple sclerosis.
- Conduction aphasia from a frontal lobe lesion.
- Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis.
- Experimental allergic neuritis: a new experimental approach.
- Conduction aphasia. A clinicopathological study.
- The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens.
- Cellular hypersensitivity in Guillain-Barré syndrome.
- Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol.
- Hemifacial spasm. Occurrence in multiple sclerosis.
- Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis.
- Multiple sclerosis-like illness occurring with human immunodeficiency virus infection.
- Multiple sclerosis and human T-cell lymphotropic retroviruses.
- CT, MR, and pathology in HIV encephalitis and meningitis.
- MR imaging of multiple sclerosis: comparison with clinical and CT examinations in 74 patients.
- D-aspartic acid in purified myelin and myelin basic protein.
- Multiple sclerosis: correlation of magnetic resonance imaging with cerebrospinal fluid findings.
- Magnetic resonance imaging of spinal cord lesions in multiple sclerosis.
- Unusual occurrence on a tropical island of multiple sclerosis.
- Multiple sclerosis (not tropical spastic paraparesis) on Key West, Florida.
- Human T lymphotropic virus type I-associated myelopathy. A report of 10 patients born in the United States.
- Event-related potential P300 in multiple sclerosis. Relation to magnetic resonance imaging and cognitive impairment.
- Association of ''(tropical) ataxic neuropathy'' with HTLV-II.
- High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy.
- Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b.
- Unusual effects of metrizamide lumbar myelography. Constellation of aseptic meningitis, arachnoiditis, communicating hydrocephalus, and Guillaine-Barré syndrome.
- Guillain-Barré syndrome complicating acute hepatitis B. A case with detailed electrophysiological and immunological studies.
- Chronic inflammatory polyradiculoneuropathy complicated by factor VIII antibody.
- Persistent neurological deficit precipitated by hot bath test in multiple sclerosis.
- Paroxysmal dystonia as the initial manifestation of multiple sclerosis.
- Alcoholic myelopathy. With spastic urinary bladder.
- Insulin-dependent diabetes mellitus and Friedreich''s ataxia in siblings.
- Reiter''s disease. A case with severe and unusual complications.
- Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis.
- HTLV-II risk factors in Native Americans in Florida.
- A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
- Glossopharyngeal neuralgia and MS.
- Elevated plasma endothelial microparticles in multiple sclerosis.
- Perverted head-shaking nystagmus: a possible mechanism.
- Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects.
Schools
University of Alberta Faculty of Medicine And Dentistry
St Pauls Hospital
Can Forces Hospital Queens
Lahey Clin Fdn
VictoriaSunnybrook Hosps
Boston VaCity Hospital
Doctors Specialties
- Internal Medicine
- Neurology
Accepted Insurances
Education
-
University of Alberta Faculty of Medicine
Drug Facts
| NPI NUMBER | 1497772826 | |
| NPPES Provider LastName | SHEREMATA | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 331361002 | |
| NPPES Provider State | FL | |
| Specialty Description | Neurology | |
| Total Claim Count | 707.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497772826 |
| Last Name Of The Provider | SHEREMATA |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
|
Dr. Paul Lindeman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irma R. Rey, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ann Hyslop, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sonia Tolgyesi, MD |
|
|
Dr. Joseph J. Thomas, MD |
|
Dr. Joseph A. Durozel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramses Ribot, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tao Tong, MD |